Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms

NCT00573521 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00573521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00573521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Completed
Start date
November 30, 2007
Completion date
June 30, 2017
Enrollment
450 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

enterobacteriaceae infections